Efficacy and Safety of Cannabinoid Oromucosal Spray for Multiple Sclerosis Spasticity
Abstract
Background: The approval of 9-δ-tetrahydocannabinol and cannabidiol (THC:CBD) oromucosal spray (Sativex) for the management of treatment-resistant multiple sclerosis (MS) spasticity opened a new opportunity for many patients...